Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer

dc.contributor.authorGoral, Vedat
dc.contributor.authorYesilbagdan, Haluk
dc.contributor.authorKaplan, Abdurahman
dc.contributor.authorSite, Dede
dc.date.accessioned2024-04-24T17:33:50Z
dc.date.available2024-04-24T17:33:50Z
dc.date.issued2007
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground/Aims: The place of CA 72-4, a new tumor marker in the prognosis of stomach cancer were studied. Methodology: Endoscopically and histologically diagnosed 47 gastric patients were studied. CEA, CA 19-9, CA 125, CA 15-3, CA 72-4 levels were measured. Results: We determined that serum CA 72-4 level in the group with cancer was significantly elevated. In patients particularly having liver metastases, CA 724 level was found to be greater. Conclusions: We are of the opinion that serum CA 72-4 level is a valuable parameter in the prognosis of stomach cancer.en_US
dc.identifier.endpage1275en_US
dc.identifier.issn0172-6390
dc.identifier.issue76en_US
dc.identifier.pmid17629087
dc.identifier.scopus2-s2.0-34347338841
dc.identifier.scopusqualityN/A
dc.identifier.startpage1272en_US
dc.identifier.urihttps://hdl.handle.net/11468/20860
dc.identifier.volume54en_US
dc.identifier.wosWOS:000247568100067
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherH G E Update Medical Publishing S Aen_US
dc.relation.ispartofHepato-Gastroenterology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastric Canceren_US
dc.subjectCa 72-4 Levelen_US
dc.titleEvaluation of CA 72-4 as a new tumor marker in patients with gastric canceren_US
dc.titleEvaluation of CA 72-4 as a new tumor marker in patients with gastric cancer
dc.typeArticleen_US

Dosyalar